Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to explore the PK/PD changes of NMN and DC cells after oral NMN combined with DC cells injection in patients after tumor surgery, and evaluate the biological age of adults, TCR diversity, SiRT1 expression level, SF-36 quality of life, OS, antigen specific immune response (TAA), cytokines and so on. In this study, 20 postoperative tumor patients who meet the entry and excretion criteria were recruited to explore the clinical potential of NMN combined with DC cell vaccine.


Clinical Trial Description

n/a


Study Design


NCT number NCT06036355
Study type Interventional
Source Shanghai Cell Therapy Group Co.,Ltd
Contact Jinxing Lou
Phone +86-18911335396
Email loujx@shcell.com
Status Not yet recruiting
Phase Early Phase 1
Start date September 30, 2023
Completion date December 30, 2024